Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Catalent
Pharma
European officials approve Novo Holdings' planned Catalent buy
Novo Holdings’ proposed $16.5 billion buyout of CDMO giant Catalent has received a major vote of confidence from antitrust officials overseas.
Fraiser Kansteiner
Dec 6, 2024 2:48pm
Roche CEO critiques Novo's proposed Catalent buyout
Oct 23, 2024 12:35pm
Consumer groups urge FTC to block Novo Holdings' Catalent deal
Oct 18, 2024 10:20am
Catalent sells NJ production plant, HQ to Belgium's Ardena
Oct 14, 2024 9:53am
Catalent reports upbeat Q4 results as it awaits review of sale
Aug 30, 2024 9:30am
Former FTC director weighs in on $16.5B Novo-Catalent deal
Jul 19, 2024 9:27am
